Honghui Capital logo

Honghui Capital

Asia, Shanghai, China, Shanghai

Description

Honghui Capital is a private equity firm that provides primarily growth capital to companies in China.

Investor Profile

Honghui Capital has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series D (33%)
  • Series C (33%)
  • Seed (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Manufacturing
  • Nutraceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Honghui Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
PICC Capital Investment Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
Jingming Capital
Asia, Shandong, China, Qingdao Shi
Co-Investments: 1
BioVenture
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
LC
North America, Washington, United States, Vancouver
Co-Investments: 1
Jiantou Huawen Investment
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Honghui Capital?

Shanghai Peptide Biotechnology

Shanghai, Shanghai, China

Shanghai Peptide Biotechnology is a developer of nutritional food and beverage products for digestive and gastrointestinal ailments.

Health CareManufacturingNutraceutical
SeedSep 29, 2024
Amount Raised: $140,000
Tongxin Medical Equipment

Suzhou, Jiangsu, China

Tongxin Medical Equipment is an artificial-heart maker company.

Biotechnology
Series DJan 25, 2022
Amount Raised: $100,000,000
Zylox

Hangzhou, Zhejiang, China

Zylox is an interventional and implantable peripheral vascular device developer.

BiotechnologyHealth CareMedical Device
Series COct 30, 2020
Amount Raised: $45,000,000